Pharvaris N.V.
PHVS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $99 | $66 | $57 | $36 |
| G&A Expenses | $47 | $31 | $29 | $18 |
| SG&A Expenses | $47 | $31 | $29 | $18 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $146 | $97 | $87 | $54 |
| Operating Income | -$146 | -$97 | -$87 | -$54 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $13 | -$3 | $11 | $11 |
| Pre-Tax Income | -$132 | -$100 | -$76 | -$43 |
| Tax Expense | $2 | $1 | $1 | $0 |
| Net Income | -$134 | -$101 | -$76 | -$43 |
| % Margin | – | – | – | – |
| EPS | -2.48 | -2.63 | -2.27 | -1.41 |
| % Growth | 5.7% | -15.9% | -61% | – |
| EPS Diluted | -2.48 | -2.63 | -2.27 | -1.41 |
| Weighted Avg Shares Out | 54 | 38 | 34 | 30 |
| Weighted Avg Shares Out Dil | 54 | 38 | 34 | 30 |
| Supplemental Information | – | – | – | – |
| Interest Income | $5 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$146 | -$97 | -$87 | -$54 |
| % Margin | – | – | – | – |